Clinical Trial Update: Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas [Phase 3]

View source ↗

Summary

Phase 3 trial update showing safety and efficacy results for AST-120 in mild-to-moderate Crohn's disease patients with intestinal fistulas; the study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Intestinal Fistula

Drugs mentioned

• Kremezin (AST-120) (AST-120)

Snippet

Sponsor: Ocera Therapeutics | Conditions: Inflammatory Bowel Disease, Intestinal Fistula | Phase 3 | Status: COMPLETED